Back to mobile site
Get it on Google Play

uniQure faces securities fraud lawsuit over FDA approval delay

March 17, 2026 10:39 PM EDT Send to a Friend
Law firm Kahn Swick & Foti has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE) in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login